PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TIANAN MEDICARE (0383.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

BMG2133H1016

Sector

Healthcare

IPO Date

Aug 1, 1991

Highlights

Market Cap

HK$846.16M

PE Ratio

26.00

Total Revenue (TTM)

HK$841.37M

Gross Profit (TTM)

HK$153.04M

EBITDA (TTM)

HK$124.69M

Year Range

HK$0.58 - HK$1.00

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in TIANAN MEDICARE, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-13.32%
9.52%
0383.HK (TIANAN MEDICARE)
Benchmark (^GSPC)

Returns By Period

TIANAN MEDICARE had a return of 6.85% year-to-date (YTD) and 14.69% in the last 12 months. Over the past 10 years, TIANAN MEDICARE had an annualized return of -13.02%, while the S&P 500 had an annualized return of 11.26%, indicating that TIANAN MEDICARE did not perform as well as the benchmark.


0383.HK

YTD

6.85%

1M

18.18%

6M

-13.33%

1Y

14.69%

5Y*

-25.32%

10Y*

-13.02%

^GSPC (Benchmark)

YTD

4.01%

1M

1.13%

6M

9.82%

1Y

22.80%

5Y*

12.93%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of 0383.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20259.59%6.85%
2024-6.25%-6.67%0.00%-2.86%2.94%0.00%8.70%13.33%-15.29%5.56%-5.26%1.39%-7.43%
2023-1.83%0.93%-10.09%10.19%-18.54%-0.00%-0.00%-1.15%1.17%-8.05%-0.00%-0.00%-26.46%
20220.00%15.94%2.50%-6.10%0.00%-1.30%10.53%-16.67%-20.00%-32.15%42.10%1.86%-20.29%
2021-11.11%0.96%5.72%2.70%7.90%-9.76%0.91%-9.82%0.99%-1.97%-18.00%-15.86%-41.03%
202010.26%-4.65%-19.51%56.06%-8.25%-8.47%-6.94%-5.59%1.97%-7.09%-30.56%17.00%-25.00%
2019-3.54%2.62%-9.18%1.12%-21.11%19.72%0.00%-11.18%0.66%7.90%-8.54%4.00%-21.21%
201823.81%-9.23%1.70%22.91%-11.86%-4.62%0.81%-10.40%13.84%-21.57%-3.50%2.59%-5.71%
20171.28%-0.00%-1.27%-1.28%-3.90%-14.86%15.87%-10.96%-7.69%-5.00%-15.09%-13.22%-46.15%
2016-19.09%-7.87%14.63%-4.26%-1.11%32.58%-30.51%6.10%-11.49%15.58%-2.25%-10.34%-29.09%
2015-11.68%5.49%9.48%9.78%215.52%-27.42%-3.33%-13.79%25.33%8.51%-5.88%14.58%213.39%
20142.16%23.28%-5.58%-6.36%-12.63%0.56%6.08%15.62%16.22%-0.39%35.80%1.84%92.12%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 0383.HK is 57, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 0383.HK is 5757
Overall Rank
The Sharpe Ratio Rank of 0383.HK is 5555
Sharpe Ratio Rank
The Sortino Ratio Rank of 0383.HK is 5555
Sortino Ratio Rank
The Omega Ratio Rank of 0383.HK is 6969
Omega Ratio Rank
The Calmar Ratio Rank of 0383.HK is 5353
Calmar Ratio Rank
The Martin Ratio Rank of 0383.HK is 5555
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for TIANAN MEDICARE (0383.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for 0383.HK, currently valued at 0.24, compared to the broader market-2.000.002.000.241.74
The chart of Sortino ratio for 0383.HK, currently valued at 0.85, compared to the broader market-4.00-2.000.002.004.006.000.852.36
The chart of Omega ratio for 0383.HK, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.32
The chart of Calmar ratio for 0383.HK, currently valued at 0.13, compared to the broader market0.002.004.006.000.132.62
The chart of Martin ratio for 0383.HK, currently valued at 0.71, compared to the broader market-10.000.0010.0020.0030.000.7110.69
0383.HK
^GSPC

The current TIANAN MEDICARE Sharpe ratio is 0.24. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of TIANAN MEDICARE with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.24
1.68
0383.HK (TIANAN MEDICARE)
Benchmark (^GSPC)

Dividends

Dividend History

TIANAN MEDICARE provided a 1.28% dividend yield over the last twelve months, with an annual payout of HK$0.01 per share.


0.00%0.50%1.00%1.50%HK$0.00HK$0.01HK$0.02HK$0.03HK$0.04HK$0.0520142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
DividendHK$0.01HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.05

Dividend yield

1.28%1.37%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.42%

Monthly Dividends

The table displays the monthly dividend distributions for TIANAN MEDICARE. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025HK$0.00HK$0.00HK$0.00
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2016HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2015HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2014HK$0.05HK$0.05

Dividend Yield & Payout


Dividend Yield
100.0%200.0%300.0%400.0%500.0%600.0%700.0%1.3%
TIANAN MEDICARE has a dividend yield of 1.28%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%32.9%
TIANAN MEDICARE has a payout ratio of 32.89%, which is quite average when compared to the overall market. This suggests that TIANAN MEDICARE strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-97.49%
-0.44%
0383.HK (TIANAN MEDICARE)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the TIANAN MEDICARE. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TIANAN MEDICARE was 99.96%, occurring on Jul 31, 2003. The portfolio has not yet recovered.

The current TIANAN MEDICARE drawdown is 97.49%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.96%Jul 6, 1999979Jul 31, 2003
-5.7%Jun 25, 19991Jun 25, 19991Jun 28, 19992
-1.85%Jun 30, 19991Jun 30, 19991Jul 2, 19992

Volatility

Volatility Chart

The current TIANAN MEDICARE volatility is 27.61%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
27.61%
2.97%
0383.HK (TIANAN MEDICARE)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of TIANAN MEDICARE over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of TIANAN MEDICARE compared to its peers in the Medical Care Facilities industry.


PE Ratio
50.0100.0150.0200.0250.026.0
The chart displays the price to earnings (P/E) ratio for 0383.HK in comparison to other companies of the Medical Care Facilities industry. Currently, 0383.HK has a PE value of 26.0. This PE ratio falls in the average range for the industry.
PEG Ratio
-1.00.01.02.03.04.05.00.0
The chart displays the price to earnings to growth (PEG) ratio for 0383.HK in comparison to other companies of the Medical Care Facilities industry. Currently, 0383.HK has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for TIANAN MEDICARE.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab